Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment

• المؤلفون الرئيسيون: Anita Bakrania (مؤلف), Gang Zheng (مؤلف), Mamatha Bhat (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2021-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death and is associated with a dismal median survival of 2-9 months. The fundamental limitations and ineffectiveness of current HCC treatments have led to the development of a vast range of nanotechnologies with the goal of...